Woburn, MA, United States of America

Arqule, Inc.


USPTO Granted Patents = 104

% Expired Patents = 17.3



Trademarks = 2

Forward Citations = 544

Loading Chart...
Loading Chart...

129 inventors (with patents filed for the assignee):

goldMedal Mark Anthony Ashwell (36 out of 45 patents)

silverMedal Manish Tandon (24 out of 24 patents)

bronzeMedal Jean-Marc Lapierre (23 out of 34 patents)

4.  Nivedita Namdev (21 out of 21 patents)

5.  Yanbin Liu (18 out of 18 patents)

6.  Rocio Palma (17 out of 17 patents)

7.  Syed M Ali (17 out of 18 patents)

8.  Jason J Hill (17 out of 55 patents)

9.  David P Reed (13 out of 13 patents)

10.  Joseph C Hogan, Jr (13 out of 13 patents)

11.  David S Casebier (12 out of 38 patents)

12.  David Vensel (12 out of 12 patents)

13.  Craig G Bates (12 out of 15 patents)

14.  Sudharshan Eathiraj (11 out of 11 patents)

15.  Chiang Jia Li (10 out of 57 patents)


Core Competencies:
Cancer Treatment
Kinase Inhibitors
Heterocyclic Compounds
Amino-Pyrrolopyrimidinone
Substituted Imidazopyridines
Pyrroloquinolinyl-Pyrrolidine
Prodrug Compositions
Triazine Derivatives

104 patents:

ArQule, Inc. is a biopharmaceutical company focused on the development and commercialization of targeted therapies for cancer and rare diseases. The company utilizes its proprietary drug discovery platform to identify and develop innovative small molecule compounds. ArQule's mission is to improve the lives of patients by advancing precision medicine through the development of novel treatments.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

Arqule, Inc.
104 Patents

#2 in Woburn, MA

#197 in Massachusetts

#3,653 in US

#7,507 in the World

Woburn, MA (US)
Woburn, MA, United States of America
Forward Citations = 544

129 inventors:

Please report any incorrect information to [email protected]
Loading…